메뉴바로가기 본문바로가기

R&D

We introduce to you SD BIOSENSOR's research center, equipped with creativity, innovation, passion, along with leading technologies and know-how.

Achievements

Research Planning Department

Research Planning Department researches and plans the feasibility of product researches and product specifications.

Sensor Development Department

Sensor Development Department aims to expand the range of products covered by developing various products from point of care products to immunodiagnostic products. It seeks to become competitive by developing products that are both convenient and accurate.

  1. 1. Immunodiagnostic reagent manufacturing technology
    • Development of various IVD products and diagnostic reagents.
    • Includes: Rapid, ELISA, FIA, and reagents of blood-borne diseases, sexually transmitted diseases, cardiovascular diseases, febrile diseases, respiratory diseases, and sexual hormones related diseases.
    • Application of source materials and measuring system through R&D network.
    • Development of highly accurate and sensitive test strips with mass production technology.
  2. 2. Biosensor technology
    • Understanding the operate principle of major biotargets, and develop technology that measures the level of physiological markers which show special reaction to biomaterials that have a function of molecular recognition like antigen-antibodies
    • Technology that use electrochemical or optical principle or markers, such as gold and fluorescence nanoparticles, to signaling the particular reaction of biomaterials.
  3. 3. Development of user-friendly products
    • POCT (Point of care test) technology which simply and rapidly diagnosis diseases
    • Function of automatic recognition of test device and items by using 2D barcode and no coding required technology

Molecular Diagnostic Development Department

Molecular Diagnostic Development Department aims for R&D of Nucleic Acid Amplification Technology, Nucleic Acid Extraction Technology, and POC cartridge technology in order to develop molecular diagnostics products for point of care tests. Human infectious diseases, drug resistant diseases are some of the areas covered for molecular diagnostic technology researches and product developments enabling early diagnostics on the scene.

  1. 01
    Nucleic Acid Amplification Technology

    Development of advanced qualitative, quantitative, and mutation analysis technique by analyzing nucleic acid amplification technology for on-site diagnosis

  2. 02
    POC cartridge technology

    Development of technology that integrates all processes such as sample infusion, fluid flow, micro-mixer, micro-pump, micro-valve, fluorescence detection, etc. into one cartridge based on the technology of Microfluidics and Bio-MEMS

  1. 03
    Nucleic Acid Extraction Technology

    Research and development of technology that applies processes such as sample preprocessing, lysis, binding, washing and elution, along with the nucleic acid amplification technology and POC cartridge technology

  2. 04
    Product Development

    Development of diagnostic products for high risk virus, tropical diseases and respiratory diseases by using potential isothermal nucleic acid amplification technology to ensure the on-site use of nucleic acid extraction and amplification in one cartridge in order to detect the target nucleic acid from the sample within a short time

Instruments Development Department

Instrument Development Department is composed with professional engineers who can perform non-stop development process from H/W level of In-Vitro diagnose system to IT service applications.

  • Development of POCT system

    in an Electro-chemical, Immuno-chromatography type

  • Retention of LIS/HIS-applied technology

    of in vitro diagnostic device recognized for its standard medical information communication by IHE America/Europe

  • Lab System

    Development of PCR and Molecular Diagnostic based

Top